Boston Scientific Corp (BSX)
90.00
-1.50
(-1.64%)
USD |
NYSE |
Nov 22, 16:00
89.98
-0.02
(-0.02%)
Pre-Market: 20:00
Boston Scientific Cash from Operations (Quarterly): 1.002B for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.002B |
| June 30, 2024 | 813.00M |
| March 31, 2024 | 164.00M |
| December 31, 2023 | 957.00M |
| September 30, 2023 | 698.00M |
| June 30, 2023 | 658.00M |
| March 31, 2023 | 190.00M |
| December 31, 2022 | 807.00M |
| September 30, 2022 | 470.00M |
| June 30, 2022 | 307.00M |
| March 31, 2022 | -58.00M |
| December 31, 2021 | 478.00M |
| September 30, 2021 | 465.00M |
| June 30, 2021 | 643.00M |
| March 31, 2021 | 284.00M |
| December 31, 2020 | 673.00M |
| September 30, 2020 | 643.00M |
| June 30, 2020 | 269.00M |
| March 31, 2020 | -77.00M |
| December 31, 2019 | 692.00M |
| September 30, 2019 | 502.00M |
| June 30, 2019 | 292.00M |
| March 31, 2019 | 350.00M |
| December 31, 2018 | 19.00M |
| September 30, 2018 | 501.00M |
| Date | Value |
|---|---|
| June 30, 2018 | -403.00M |
| March 31, 2018 | 193.00M |
| December 31, 2017 | 684.00M |
| September 30, 2017 | 452.00M |
| June 30, 2017 | 297.00M |
| March 31, 2017 | -7.00M |
| December 31, 2016 | 676.00M |
| September 30, 2016 | -31.00M |
| June 30, 2016 | 421.00M |
| March 31, 2016 | 116.00M |
| December 31, 2015 | 420.00M |
| September 30, 2015 | 408.00M |
| June 30, 2015 | 60.00M |
| March 31, 2015 | -197.00M |
| December 31, 2014 | 440.00M |
| September 30, 2014 | 346.00M |
| June 30, 2014 | 285.00M |
| March 31, 2014 | 198.00M |
| December 31, 2013 | 275.00M |
| September 30, 2013 | 251.00M |
| June 30, 2013 | 397.00M |
| March 31, 2013 | 187.00M |
| December 31, 2012 | 389.00M |
| September 30, 2012 | 272.00M |
| June 30, 2012 | 407.00M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-77.00M
Minimum
Mar 2020
1.002B
Maximum
Sep 2024
503.90M
Average
560.50M
Median
Cash from Operations (Quarterly) Benchmarks
| Baxter International Inc | 253.00M |
| Haemonetics Corp | 48.82M |
| ResMed Inc | 325.54M |
| Globus Medical Inc | 203.65M |
| Abbott Laboratories | 2.705B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -1.427B |
| Cash from Financing (Quarterly) | 7.00M |
| Free Cash Flow | 1.892B |
| Free Cash Flow Per Share (Quarterly) | 0.4693 |
| Free Cash Flow to Equity (Quarterly) | 384.00M |
| Free Cash Flow to Firm (Quarterly) | 753.38M |
| Free Cash Flow Yield | 1.42% |